home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Gene Involved In Digeorge Syndrome Identified

  March, 1 2001 3:34
your information resource in human molecular genetics

In the 1 March issue of Nature (Vol. 410, No. 6824, 01 March 2001), researchers from Baylor College of Medicine in Texas pinpoint the gene behind one of the most common genetic diseases to affect humans: DiGeorge syndrome.

The disease results in a broad spectrum of symptoms, including heart abnormalities, disruption of the immune system and facial morphology. DiGeorge syndrome affects around 1 in 4,000 babies born, and next to Down syndrome it is the most common genetic cause of heart defects.

DiGeorge syndrome is caused by deletions of large sections of DNA from our smallest chromosome: chromosome 22. Up to one tenth of this chromosome’s 33 million DNA base pairs can be missing from the genome of DiGeorge syndrome patients. A large number of genes lie within this section of DNA (known as 22q11.2), but until now researchers have been unable to pinpoint the exact gene, or genes, which directly cause the disease.

Antonio Baldini and colleagues used state-of-the-art genetic techniques to test a number of candidate genes in a mouse model of DiGeorge syndrome. This model allows them to identify a gene known as Tbx1— a control gene that switches on the expression of other genes during development—as being responsible for the main cardiac symptoms of the disease. The finding brings to an end the long search for a gene involved in DiGeorge syndrome, and provides scientists with insight into both the disease, and the normal development of complex organs like the heart.


Antonio Baldini
tel +1 713 798 6519
e-mail baldini@bcm.tmc.edu

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.